Patrick Scicluna
Overview
Explore the profile of Patrick Scicluna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
73
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scicluna P, Caramuta S, Kjellin H, Xu C, Frobom R, Akhtar M, et al.
Int J Oncol
. 2022 Sep;
61(5).
PMID: 36169175
Abnormalities of the insulin‑like growth factor 2 locus with the overexpression of are frequent findings in adrenocortical carcinoma (ACC). The present study assessed the expression of RNAs and microRNAs (miRNAs/miRs)...
2.
Zheleznyakova G, Piket E, Needhamsen M, Hagemann-Jensen M, Ekman D, Han Y, et al.
Proc Natl Acad Sci U S A
. 2021 Apr;
118(17).
PMID: 33879606
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease affecting the central nervous system (CNS). Small non-coding RNAs (sncRNAs) and, in particular, microRNAs (miRNAs) have frequently been associated with MS....
3.
Regulation of LDHB Plays Distinct Roles in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma
Kumar S, Xie H, Scicluna P, Lee L, Bjornhagen V, Hoog A, et al.
Cancers (Basel)
. 2018 Nov;
10(11).
PMID: 30441870
() is deregulated in multiple tumor types and regulates important targets involved in tumorigenesis and metastasis. This miRNA is highly expressed in Merkel cell carcinoma (MCC) compared to normal skin...
4.
Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Vasaikar S, Tsipras G, Landazuri N, Costa H, Wilhelmi V, Scicluna P, et al.
BMC Cancer
. 2018 Feb;
18(1):154.
PMID: 29409474
Background: Glioblastoma (GBM) is the most common malignant brain tumor with median survival of 12-15 months. Owing to uncertainty in clinical outcome, additional prognostic marker(s) apart from existing markers are...
5.
Xie H, Lee L, Scicluna P, Kavak E, Larsson C, Sandberg R, et al.
Int J Cancer
. 2014 Aug;
136(5):E230-41.
PMID: 25156441
Altered expression of specific microRNAs (miRNAs) has been observed in human cervical cancer. However, the biological functions of many of these miRNAs are yet to be discovered. We previously showed...